Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Rejuvel Bio-Sciences, Inc. Subsidiary Announces First Order From New Business Relationship With Digicom

NUUU

PEMBROKE PINES, FL--(Marketwired - Aug 31, 2016) - Rejuvel Bio-Sciences, Inc. (OTC PINK: NUUU) is a NASA Technology Transfer Partner and creator of REJUVEL 3D Ageless Infinity Microgravity Cell Renewal Cream. Rejuvel is the only company in the world to exclusively use patented NASA technology licensed from the National Aeronautics and Space Administration and Administrators of the Tulane Educational Fund under U.S. Patent Nos. 6,730,498 and 6,485,963 B1 and 6,673,597 B2 to manufacture topical cosmetics and hair care products.

Rejuvel announced today that its wholly-owned subsidiary, Rejuvel Int'l, Inc., has received its first order from a newly formed relationship with Digicom, an Istanbul based retailer of consumer and cosmetics goods. This order represents Rejuvel's continuing and growing presence in the personal goods and cosmetics markets in Eastern Europe.

"We look forward to developing the relationship with Digicom, a multi-faceted Turkish company, and to continue to register and sell our products in various countries around the world. We see Rejuvel as a worldwide brand that can help people everywhere achieve better looking skin by using our products. In other developments, we are working towards filing the proper SEC documents to regain our fully reporting status," said Charles Scimeca, President of Rejuvel.

The Company also announced that it recently met with an International Trade Specialist at the U.S. Commercial Service which is an agency of the U.S. Department of Commerce, and also met with the Regional Director of the Eastern Region of the Export-Import Bank of the United States. The U.S. Commercial Service, whose website is at www.trade.gov, assists and guides small and medium sized American companies through the product export process into most countries around the world. Rejuvel is looking forward to receiving sales leads though the agency's listing website and is also exploring ways of providing credit to its overseas customers, through The Export-Import Bank of the United States, which it believes will lead to larger orders and more sales revenue.

Rejuvel creates one of the most unique anti-aging face creams in the world. The key ingredient in REJUVEL 3D is derived from the stem cells of a type of green tea plant, Camellia Sinensis, that are expanded in a special bioreactor developed by NASA engineers which mimics the microgravity conditions of outer space. This process greatly increases the activity of the cells and promotes your body's own healing mechanisms. Because cells grow differently in microgravity, the potency of these cells is far superior to that of cells grown using traditional methods. Dermatologists, facial experts, wellness center clients and our customers that have tried our Rejuvel 3D product report amazing results. Rejuvel has recently been awarded the bronze medal in the Truth In Aging Olympics: MVP category. Previously, Truth In Aging had awarded Rejuvel its Most Innovative Formula of 2015 award.

For more information about NUUU please visit the corporate website at: www.rejuvel.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Rejuvel Bio-Sciences, Inc. (NUUU)
Marc Frankel
Operations Manager
800-670-0448
www.rejuvel.com
info@rejuvel.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today